Search

Einar M Sigurdsson

from Scarsdale, NY
Age ~54

Einar Sigurdsson Phones & Addresses

  • 23 Downer Ave, Scarsdale, NY 10583 (914) 472-1972
  • 23 Downer Ave, Scarsdale, NY 10583 (914) 472-1972
  • 131 93Rd St, New York, NY 10128
  • 120 Suffolk St, New York, NY 10002
  • Westchester, NY
  • Chicago, IL
  • Broadview, IL

Resumes

Resumes

Einar Sigurdsson Photo 1

Assistant Professor At Nyu School Of Medicine

View page
Position:
Assistant Professor at NYU School of Medicine
Location:
Greater New York City Area
Industry:
Higher Education
Work:
NYU School of Medicine
Assistant Professor
Einar Sigurdsson Photo 2

Associate Professor At New York University

View page
Position:
Associate Professor at New York University
Location:
Greater New York City Area
Industry:
Higher Education
Work:
New York University
Associate Professor

Publications

Wikipedia References

Einar Sigurdsson Photo 3

Einar Sigurdsson

About:
Died:

1020

Work:

Thorfinn was only a child, whereas his three brothers were grown men, so the Earldom was divided between the three older brothers....

Education:

The " Orkneyinga Saga " describes Einar as " ruthless and grasping, a hard and successful fighting man " and that he " made no compromises and stood no arguments.

Skills & Activities:
Preference:

Mate

Wikipedia

Einar Sigurdss

View page

Einar Sigurdsson (died 1020), also called Einar Wry-Mouth, was a son of Sigurd Hlodvirsson. He was jointly Earl of Orkney from 1014. His life is recorded in the Orkneyinga Saga.

Us Patents

Synthetic Immunogenic But Non-Amyloidogenic Peptides Homologous To Amyloid For Induction Of An Immune Response To Amyloid And Amyloid Deposits

View page
US Patent:
6713450, Mar 30, 2004
Filed:
May 22, 2001
Appl. No.:
09/861847
Inventors:
Blas Frangione - New York NY
Thomas Wisniewski - Staten Island NY
Einar M. Sigurdsson - New York NY
Assignee:
New York University - New York NY
International Classification:
A61K 3800
US Classification:
514 12, 530300, 4241981
Abstract:
The present invention relates to synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid which can be used alone or conjugated to an immunostimulatory molecule in an immunizing composition for inducing an immune response to amyloid peptides and amyloid deposits.

Detection Of Alzheimers Amyloid By Magnetic Resonance Imaging

View page
US Patent:
6821504, Nov 23, 2004
Filed:
May 23, 2002
Appl. No.:
10/151614
Inventors:
Thomas Wisniewski - Staten Island NY
Daniel Turnbull - Larchmont NY
Einar Sigurdsson - New York NY
Youssef Zaim Wadghiri - New York NY
Assignee:
New York University - New York NY
International Classification:
A61K 5100
US Classification:
424 169, 424 111, 424 165, 424 91, 424 93
Abstract:
Alzheimers disease can be diagnosed in vivo using magnetic resonance imaging. A labeled A peptide or its derivative is injected into the patient to be diagnosed, after which the patient is subjected to magnetic resonance imaging. Both pre-amyloid and amyloid plaques can be detected using this method.

Synthetic Immunogenic But Non Amyloidogenic Peptides Homologous To Amyloid Β For Induction Of An Immune Response To Amyloid Β And Amyloid Deposits

View page
US Patent:
7427655, Sep 23, 2008
Filed:
Sep 19, 2003
Appl. No.:
10/666423
Inventors:
Blas Frangione - New York NY,
Thomas Wisniewski - Staten Island NY,
Einar M. Sigurdsson - Scarsdale NY,
Assignee:
New York University - New York NY
International Classification:
A61K 38/00
US Classification:
530300, 530324, 4241841, 4241851, 42419511
Abstract:
The present invention relates to synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β which can be used alone or conjugated to an immunostimulatory molecule in an immunizing composition for inducing an immune response to amyloid β peptides and amyloid deposits.

Synthetic Immunogenic But Non-Deposit-Forming Polypeptides And Peptides Homologous To Amyloid Β, Prion Protein, Amylin, Α-Synuclein, Or Polyglutamine Repeats For Induction Of An Immune Response Thereto

View page
US Patent:
7479482, Jan 20, 2009
Filed:
Nov 21, 2002
Appl. No.:
10/301488
Inventors:
Blas Frangione - New York NY,
Thomas Wisniewski - Statent Island NY,
Einar M. Sigurdsson - New York NY,
Assignee:
New York University - New York NY
International Classification:
A61K 38/16
C07K 14/00
C07K 19/00
US Classification:
514 12, 530300, 530350
Abstract:
The present invention relates to immunogenic but non-depositing-forming polypeptides or peptides homologous to amyloid β, prion, amylin or α-synuclein which can be used alone or conjugated to an immunostimulatory molecule in an immunizing composition for inducing an immune response to amyloid β peptides and amyloid deposits, to prion protein and prion deposits, to amylin and amylin deposits, to α-synuclein and deposits containing α-synuclein, or to polyglutamine repeats and deposits of proteins containing polyglutamine repeats. Described are also antibodies directed against such peptides, their generation, and their use in methods of passive immunization to such peptides and deposits.

Treatment Of Alzheimer Amyloid Deposition

View page
US Patent:
7632816, Dec 15, 2009
Filed:
Mar 26, 2004
Appl. No.:
10/810919
Inventors:
Thomas Wisniewski - Staten Island NY,
Marcin Sadowski - Bronx NY,
Einar M. Sigurdsson - New York NY,
Blas Frangione - New York NY,
Assignee:
New York University - New York NY
International Classification:
A61K 38/00
A61K 38/04
A61K 39/00
A01N 37/18
C07K 14/00
C07K 16/00
US Classification:
514 13, 514 2, 530326, 530300, 530332, 4241851
Abstract:
The present invention is directed to a method of preventing or treating Alzheimer's Disease or of inhibiting accumulation of amyloid-β deposits in a subject by administering to the subject an agent which inhibits interaction between amyloid-β and proteins which chaperone amyloid-β under conditions effective to prevent or treat Alzheimer's Disease in the subject or to inhibit accumulation of amyloid-β deposits in the subject's brain, respectively. Another embodiment of the present invention relates to a method of inhibiting interaction between apolipoprotein E and amyloid-β by administering an agent which blocks interaction of apolipoprotein E and amyloid-β under conditions effect to block such interaction.

Synthetic Immunogenic But Non-Amyloidogenic Peptides Homologous To Amyloid Β For Induction Of An Immune Response To Amyloid Β And Amyloid Deposits

View page
US Patent:
7700107, Apr 20, 2010
Filed:
Sep 19, 2008
Appl. No.:
12/234456
Inventors:
Blas Frangione - New York NY,
Thomas Wisniewski - Staten Island NY,
Einar M. Sigurdsson - Scarsdale NY,
Assignee:
New York University - New York NY
International Classification:
A61K 39/38
US Classification:
4241841, 4241851, 514 12, 530300
Abstract:
The present invention relates to synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β which can be used alone or conjugated to an immunostimulatory molecule in an immunizing composition for inducing an immune response to amyloid β peptides and amyloid deposits.

Tau Fragments For Immunotherapy

View page
US Patent:
8012936, Sep 6, 2011
Filed:
Mar 29, 2007
Appl. No.:
11/693375
Inventors:
Einar Sigurdsson - New York NY,
Ayodeji Asuni - New York NY,
Assignee:
New York University - New York NY
International Classification:
A61K 38/00
A01N 37/18
US Classification:
514 178, 514 177, 514 213, 530324, 530300
Abstract:
The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions effective to treat or prevent Alzheimer's Disease of other tauopathies. Also disclosed are methods of promoting clearance of aggregates from the brain of the subject and of slowing progression of tangle-related behavioral phenotype in a subject.

Method For Treating Amyloid Disease

View page
US Patent:
8318175, Nov 27, 2012
Filed:
Feb 5, 2009
Appl. No.:
12/366126
Inventors:
Blas Frangione - New York NY,
Einar M. Sigurdsson - Scarsdale NY,
Thomas Wisniewski - Staten Island NY,
Jorge Ghiso - Elmhurst NY,
Assignee:
New York University - New York NY
International Classification:
A61K 39/00
US Classification:
4241851
Abstract:
Disclosed herein are methods for treating amyloid disease in humans by clearing amyloid peptides from one or more bodily fluids such as, e. g. blood, of a patient. In particular, the methods are based on the administration of compounds capable of binding to amyloid-beta (Aβ) or on dialysis of blood or plasma exchange in order to remove Aβ peptides from the blood circulation, and/or brain or other affected organs.
Einar M Sigurdsson from Scarsdale, NY, age ~54 Get Report